Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium

OBJECTIVE: To test the diagnostic performance of percent free prostate-specific antigen (%fPSA) in predicting any prostate cancer (PCa) and high-grade prostate cancer (HGPCa) in a retrospective multi-center biopsy cohort with a PSA level of 4.0–10.0 ng/mL in China. METHODS: Consecutive patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui, Xie, Liping, Cai, Xiaobing, Huang, Yiran, Zhou, Liqun, Ma, Lulin, Gao, Xu, Xu, Chuanliang, Ren, Shancheng, Shao, Pengfei, Xu, Danfeng, Xu, Kexin, Ye, Zhangqun, Liu, Chunxiao, Ye, Dingwei, Lu, Li, Fu, Qiang, Hou, Jianquan, Yuan, Jianlin, He, Dalin, Zhou, Tie, Wang, Fubo, He, Biming, Sun, Yinghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730736/
https://www.ncbi.nlm.nih.gov/pubmed/29264128
http://dx.doi.org/10.1016/j.ajur.2015.04.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730736/
https://www.ncbi.nlm.nih.gov/pubmed/29264128
http://dx.doi.org/10.1016/j.ajur.2015.04.022

Ejemplares similares